Skip to content
FIND A HEALTH VALLEY ACTOR

Lonza: 300 jobs in Visp for a new vaccine

Ibex™ Lonza facilit in Visp Switzerland

Lonza’s Visp site is preparing to manufacture components of a vaccine to protect against pneumococcus. Hundreds of jobs are at stake.     For Lonza, each day is different. After losing the contract to produce the active ingredients of the anti-Covid vaccine designed by Moderna, the company has just extended its collaboration with Californian company…

Read More

Hedera Dx Launches Blood Based Cancer Testing

Hedera Dx

Hedera Dx, a Vaud-based oncology company specializing in liquid biopsy testing, has unveiled a fully streamlined solution that allows hospitals to adopt liquid biopsy testing locally for their patients with minimal efforts. The solution is a combination of laboratory reagents and a software platform.     Liquid biopsies provide rapid, precise, non-invasive ways of assessing…

Read More

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca

SOPHiA GENETICS

The three companies will collaborate to address global inequalities in comprehensive cancer care, and to improve global access to advanced cancer testing and data, broadening access to cutting edge science     SOPHiA GENETICS, a category-defining software company and a global leader in data-driven medicine,  announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK),…

Read More

A visit at Mecaplast Swiss

Mecaplast Swiss - 4à6

Over the decades, Mecaplast Swiss has extended its offering beyond plastic injection per-say. The company may collaborate as early as the design phase, up to shipping fully finished products to its clients across the globe. The new ISO 7 clean room strengthens the offer as it is mainly be dedicated to the post-injection operations, assembly, finishing and packaging to meet the fast-growing demand of the MedTech industry.

Read More

Healthcare Konnect (HCK) and Coreline Europe GmbH start a partnership

HCK Coreline

Healthcare Konnect (HCK) and Coreline Europe GmbH start a new partnership to amplify the inherent value of diagnostic accuracy.     Healthcare Konnect (HCK) is Geneva-based company that created a shared platform providing health organisations access to world-leading AI solutions to assist medical diagnostics. The HCK Hub, HCK’s propriety platform, routes anonymised patients’ data to…

Read More

Limula SA receives CHF 2.5 million from Innosuisse Swiss Accelerator

Limula

Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution for Cell and Gene Therapy manufacturing.   Swiss company won highly competitive funding provided by the country’s innovation agency Innosuisse through its Swiss Accelerator programme. Funding will support the transition from R&D to commercial activities,…

Read More

machineMD wins Innovation World Cup 2023

machineMD

machineMD, a Bern-based medtech company, was awarded the top prize at the prestigious Innovation World Cup® 2023, hosted during the 43rd Wearable Technologies conference in Munich on 24 April 2023.   Europe’s Top12 wearables startups gathered for the official WT Innovation World Cup® 2023 Pitch & Award ceremony. These Top12 techpreneurs were selected from over…

Read More

Siegfried expands and invests CHF 25 million in Evionnaz (VS)

Siegfried

The biomanufacturing company invests of up to CHF 25 million in Valais (Switzerland) for a new global R&D Center for drug substances   Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) headquartered in Zofingen, broke ground for its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz,…

Read More

SydLab One by Nagi Bioscience hits the market

Nagi Bioscience's team

Nagi Bioscience releases an end-to-end automated device to screen drugs, chemicals and others substances on micro-organisms.   Swiss EPFL spin-off Nagi Bioscience, a biotech start-up specialized in developing innovative alternatives to animal testing, announces today the commercialization of their first full product solution: SydLab One. Under the premise of unlocking the whole potential of micro-organisms as…

Read More